Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 3.37% vs 175.71% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -52.36% vs -4.01% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 143.64% vs 23.01% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -70.63% vs -195.98% in Mar 2025
Compare Profit and Loss Results of Oxygenta Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
112.00
120.00
-8.00
-6.67%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
112.00
120.00
-8.00
-6.67%
Expenditure (Ex Depriciation)
Stock Adjustments
-8.00
-1.00
-7.00
-700.00%
Raw Materials Consumed
110.00
46.00
64.00
139.13%
Power & Fuel Cost
6.00
4.00
2.00
50.00%
Employee Cost
7.00
41.00
-34.00
-82.93%
Operating Expenses
8.00
4.00
4.00
100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
5.00
-5.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
7.00
-7.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
128.00
123.00
5.00
4.07%
Operating Profit (PBDIT) excl Other Income
-15.00
-2.00
-13.00
-650.00%
Other Income
0.00
3.00
-3.00
-100.00%
Operating Profit (PBDIT)
-15.00
1.00
-16.00
-1,600.00%
Interest
4.00
3.00
1.00
33.33%
Profit before Depriciation and Tax
-19.00
-1.00
-18.00
-1,800.00%
Depreciation
2.00
8.00
-6.00
-75.00%
Profit Before Taxation & Exceptional Items
-22.00
-10.00
-12.00
-120.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-22.00
-33.00
11.00
33.33%
Provision for Tax
-4.00
0.00
-4.00
0%
Profit After Tax
-17.00
-32.00
15.00
46.88%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-74.00
-112.00
38.00
33.93%
Profit Available for appropriations
-91.00
-144.00
53.00
36.81%
Appropriations
-91.00
-144.00
53.00
36.81%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-4.75
-9.05
4.30
47.51%
Profit And Loss - Net Sales
Net Sales 112.98 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 3.37% vs 175.71% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -15.37 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -52.36% vs -4.01% in Mar 2025
Profit And Loss - Interest
Interest 4.78 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 143.64% vs 23.01% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax -17.57 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -70.63% vs -195.98% in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
